These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31848474)

  • 1. Host-microbiota interactions in inflammatory bowel disease.
    Neurath MF
    Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):76-77. PubMed ID: 31848474
    [No Abstract]   [Full Text] [Related]  

  • 2. Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach.
    Verma A; Sharda S; Rathi B; Somvanshi P; Pandey BD
    Sci Rep; 2020 Sep; 10(1):15131. PubMed ID: 32934294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
    Fritsch J; Abreu MT
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Integrative Human microbiome project: a mile stone in the understanding of the gut microbiome.
    Voth E; Khanna S
    Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):639-642. PubMed ID: 32515629
    [No Abstract]   [Full Text] [Related]  

  • 6. The Human Gut Microbiota.
    Harmsen HJ; de Goffau MC
    Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage interactions with fungi and bacteria in inflammatory bowel disease.
    Leonardi I; Li X; Iliev ID
    Curr Opin Gastroenterol; 2018 Nov; 34(6):392-397. PubMed ID: 30239343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders.
    Macchione IG; Lopetuso LR; Ianiro G; Napoli M; Gibiino G; Rizzatti G; Petito V; Gasbarrini A; Scaldaferri F
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8075-8083. PubMed ID: 31599433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intestinal barrier, an arbitrator turned provocateur in IBD.
    Mehandru S; Colombel JF
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):83-84. PubMed ID: 33318680
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intestinal immune response is regulated by gut microbe].
    Tanemoto S; Sujino T; Kanai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enteric microflora in inflammatory bowel disease patients].
    Rahmouni O; Dubuquoy L; Desreumaux P; Neut C
    Med Sci (Paris); 2016 Nov; 32(11):968-973. PubMed ID: 28008837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Innate Immune System in the Gastrointestinal Tract: Role of Intraepithelial Lymphocytes and Lamina Propria Innate Lymphoid Cells in Intestinal Inflammation.
    Montalban-Arques A; Chaparro M; Gisbert JP; Bernardo D
    Inflamm Bowel Dis; 2018 Jul; 24(8):1649-1659. PubMed ID: 29788271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.